HTA46 Outcomes of Benefit Assessments of Orphan Drugs Without Orphan Designation in Germany
| Autor: | Frick, L, Qiu, Z, Schönermark, M |
|---|---|
| Zdroj: | In Value in Health December 2022 25(12) Supplement:S305-S305 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
| Autor: | Frick, L, Qiu, Z, Schönermark, M |
|---|---|
| Zdroj: | In Value in Health December 2022 25(12) Supplement:S305-S305 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect